Korea-EU poles apart on medicine talks

Published: 2007-10-10 06:56:00

Updated: 2007-10-10 06:56:00

Korea and the European Union (EU) remain far apart in their negotiations over the possible opening of the domestic market for pharmaceuticals and other healthcare industries, according to a government official.

The EU has also threatened to withdraw its market liberalization plan unless Korea ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK